Seneca Biopharma (CUR) Stock Climbs On License Agreement
Seneca Biopharma, Inc. (NASDAQ: CUR) (previously known as Neuralstem) is flying early on in the trading session, trading on gains of around 30%. The gains… Read More »Seneca Biopharma (CUR) Stock Climbs On License Agreement